侵入性形癌的特征 侵入性形癌的特征
Ryusei Yoshino1, Masaki Nakatsubo1, Nanami Ujiie1
1Department of Thoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Hokkaido, Asahikawa-shi, Japan.
Cancer investigation
|July 26, 2024
概括
侵入性形癌 (ICC) 是一种罕见的乳腺癌亚型. 这项研究发现,ICC一般具有良好的预后,是激素受体阳性,但需要对HER2阳性病例进行监测.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 侵入性形癌 (ICC) 是一种罕见的恶性乳腺瘤.
- ICC的特点是生长缓慢,预后通常有利.
研究的目的:
- 为了研究侵入性形癌的临床病理特征.
- 为了确定ICC患者的预后指标.
主要方法:
- 一个单一中心的回顾性研究.
- 对乳腺癌患者数据 (n=2454) 的分析,以确定ICC病例 (n=8).
- 评估受体状态,包括雌激素受体 (ER),孕激素受体 (PR) 和人体表皮生长因子受体2型 (HER2).
主要成果:
- 在研究队列中,侵入性cribriform癌症占所有乳腺癌诊断的0.3%.
- 所有确定的ICC病例都是激素受体阳性 (ER或PR阳性).
- 一个病例 (12.5%) 呈阳性HER2检测,表明需要特殊管理的子集.
结论:
- 侵入性cribriform癌症通常呈现为低度,激素受体阳性,发光型乳腺癌,预后良好.
- 在一小部分ICC患者中存在HER2阳性,需要仔细跟踪和量身定制的治疗策略.
相关概念视频
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


